UBUS:XETRA:XETRA-UBS (Irl) ETF plc - Factor MSCI USA Prime Value UCITS ETF (USD) A-dis (EUR)

ETF | Others |

Last Closing

USD 33.14

Change

-0.09 (-0.27)%

Market Cap

USD 0.49B

Volume

18.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.47 (-0.93%)

USD 484.40B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.15 (-0.92%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.27 (-1.00%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.26 (-0.92%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.16 (-0.65%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-1.72 (-1.23%)

USD 98.29B
JARI:XETRA Amundi Index Solutions - Amund..

-0.62 (-1.35%)

USD 98.25B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.42 (-0.83%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-2.62 (-0.49%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.26 (-1.15%)

USD 79.79B

ETFs Containing UBUS:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.02% 72% C 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.02% 72% C 70% C-
Trailing 12 Months  
Capital Gain 17.79% 74% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.79% 74% C 72% C
Trailing 5 Years  
Capital Gain 64.79% 82% B 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 64.79% 82% B 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 13.27% 83% B 80% B-
Dividend Return 14.01% 84% B 80% B-
Total Return 0.74% 56% F 36% F
Risk Return Profile  
Volatility (Standard Deviation) 15.03% 36% F 48% F
Risk Adjusted Return 93.23% 93% A 94% A
Market Capitalization 0.49B 65% D 57% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.